the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences

Market Research Report

United States Cardiovascular Devices Market Analysis and Forecasts to 2015

Published by GlobalData Contact us : +1-860-674-8796
Published 2009/07 Content info Pages: 422
Product code GD97118
Price From  US $ 3500 Order/Price list
US $ 3500 PDF by E-mail (Single user license)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Table of Contents

1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 18
2 Introduction 21
2.1 What Is This Report About? 21
3 Definitions of Markets Covered in the Report 22
3.1 Cardiovascular Devices 22
3.2 Cardiac Rhythm Management 22
3.3 Cardiovascular Monitoring and Diagnostic Devices 23
3.4 Cardiovascular Prosthetic Device 24
3.5 Cardiovascular Surgery 25
3.6 Electrophysiology 26
3.7 Interventional Cardiology 26
3.8 Peripheral Vascular Devices 28
4 Healthcare Sector Review 29
4.1 Healthcare Expenditure 29
4.2 Healthcare Infrastructure 34
4.3 US Healthcare Trade Statistics 42
5 Regulation System 43
5.1 Regulation System 43
5.2 Medical Equipment Approval Process 43
6 Pricing and Reimbursement 50
6.1 Government Policies 50
6.2 Private Insurance 51
6.3 Diagnosis Related Groups (DRG) 52
7 Distribution Structure 53
7.1 Distribution Structure 53
8 Cardiovascular Devices In US 54
8.1 Cardiovascular Devices, US, Overall Revenue ($ mn), 2000-2015 54
8.2 Cardiovascular Devices, US, Category Volume (Units), 2000-2015 58
8.3 Cardiovascular Devices, US, Cross Category Analysis, 2000 – 2015 60
8.4 Cardiovascular Devices, US, Company Share (2007-2008) 61
9 Cardiac Rhythm Management In US 62
9.1 Cardiac Rhythm Management Overall Revenue (2000-2015) 62
9.2 Cardiac Rhythm Management Overall Volume (2000-2015) 71
9.3 Cardiac Rhythm Management Average Price (2000-2015) 73
9.4 Cardiac Rhythm Management Market, Cross Segment Analysis 74
9.5 Cardiac Rhythm Management Market Dynamics 75
9.6 Cardiac Rhythm Management Distribution Share (2007-2008) 76
9.7 Cardiac Rhythm Management, US, Company Share (2007-2008) 77
9.8 Cardiac Rhythm Management Future Outlook 78
10 Cardiovascular Monitoring and Diagnostic Devices In US 79
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2015) 79
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2015) 82
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2000-2015) 84
10.4 Cardiovascular Monitoring and Diagnostic Devices Market, Cross Segment Analysis 85
10.5 Cardiovascular Monitoring & Diagnostic Devices Market Dynamics 86
10.6 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2007-2008) 86
10.7 Cardiovascular Monitoring and Diagnostic Devices, US, Company Share (2007-2008) 87
10.8 Cardiovascular Monitoring and Diagnostic Devices Future Outlook 88
11 Cardiovascular Prosthetic Devices In US 89
11.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2015) 89
11.2 Cardiac Assist Devices Revenue (2000-2015) 93
11.3 Cardiovascular Prosthetic Devices Overall Volume (2000-2015) 98
11.4 Cardiovascular Prosthetic Devices Average Price (2000-2015) 100
11.5 Cardiovascular Prosthetic Devices Market, Cross Segment Analysis 101
11.6 Cardiovascular Prosthetic Devices Market Dynamics 102
11.7 Cardiovascular Prosthetic Devices Distribution Share (2007-2008) 103
11.8 Cardiovascular Prosthetic Devices, US, Company Share (2007-2008) 104
11.9 Cardiovascular Prosthetic Devices Future Outlook 105
12 Cardiovascular Surgery In US 106
12.1 Cardiovascular Surgery Overall Revenue (2000-2015) 106
12.2 Cardiovascular Surgery Overall Volume (2000-2015) 109
12.3 Cardiovascular Surgery Average Price (2000-2015) 111
12.4 Cardiovascular Surgery Market, Cross Segment Analysis 112
12.5 Cardiovascular Surgery Market Dynamics 113
12.6 Cardiovascular Surgery Distribution Share (2007-2008) 114
12.7 Cardiovascular Surgery, US, Company Share (2007-2008) 115
12.8 Cardiovascular Surgery Future Outlook 116
13 Electrophysiology In US 117
13.1 Electrophysiology Overall Revenue (2000-2015) 117
13.2 Electrophysiology Overall Volume (2000-2015) 119
13.3 Electrophysiology Average Price (2000-2015) 120
13.4 Electrophysiology Market, Cross Segment Analysis 121
13.5 Electrophysiology Market Dynamics 122
13.6 Electrophysiology Distribution Share (2007-2008) 123
13.7 Electrophysiology, US, Company Share (2007-2008) 124
13.8 Electrophysiology Future Outlook 125
14 Interventional Cardiology In US 126
14.1 Interventional Cardiology Overall Revenue (2000-2015) 126
14.2 Interventional Cardiology Overall Volume (2000-2015) 137
14.3 Interventional Cardiology Average Price (2000-2015) 139
14.4 Interventional Cardiology Market, Cross Segment Analysis 141
14.5 Interventional Cardiology Market Dynamics 142
14.6 Interventional Cardiology Distribution Share (2007-2008) 143
14.7 Interventional Cardiology, US, Company Share (2007-2008) 144
14.8 Interventional Cardiology Future Outlook 145
15 Peripheral Vascular Devices In US 146
15.1 Peripheral Vascular Devices Overall Revenue (2000-2015) 146
15.2 Peripheral Vascular Devices Overall Volume (2000-2015) 150
15.3 Peripheral Vascular Devices Average Price (2000-2015) 154
15.4 Peripheral Vascular Devices Market, Cross Segment Analysis 155
15.5 Peripheral Vascular Devices Market Dynamics 156
15.6 Peripheral Vascular Devices Distribution Share (2007-2008) 157
15.7 Peripheral Vascular Devices, US, Company Share (2007-2008) 158
15.8 Peripheral Vascular Devices Future Outlook 159
16 Overview of Key Companies in US Cardiovascular Devices Market 160
16.1 Boston Scientific Corporation Company Profile 160
16.2 Medtronic, Inc. Company Profile 170
16.3 Cordis Corporation Company Profile 181
16.4 St. Jude Medical Inc. Company Profile 184
16.5 Abbott Laboratories Company Profile 191
16.6 Terumo Corporation Company Profile 196
16.7 Abbott Vascular Company Profile 201
16.8 ABIOMED, Inc. Company Profile 205
16.9 AGA Medical Corporation Company Profile 210
16.10 Angel Medical Systems, Inc. Company Profile 212
16.11 Arrow International, Inc. Company Profile 213
16.12 Ash Access Technology, Inc. Company Profile 218
16.13 AtriCure, Inc. Company Profile 219
16.14 Atritech, Inc. Company Profile 221
16.15 Atrium Medical Corporation Company Profile 223
16.16 ATS Medical, Inc. Company Profile 225
16.17 BioCardia, Inc. Company Profile 227
16.18 Bioheart, Inc. Company Profile 228
16.19 Biosite Incorporated Company Profile 230
16.20 BIOTRONIK GmbH & Co. KG 236
16.21 Bolton Medical, Inc. Company Profile 238
16.22 C.R. Bard, Inc. Company Profile 239
16.23 Cardiac Dimensions, Inc. Company Profile 245
16.24 Cardiac Science Corporation Company Profile 247
16.25 Cardica, Inc. Company Profile 250
16.26 Cardima, Inc. Company Profile 251
16.27 Cardiovascular Systems, Inc. Company Profile 253
16.28 CONMED Corporation Company Profile 254
16.29 Cook Medical Company Profile 258
16.30 Datascope Corporation Company Profile 261
16.31 Edwards Lifesciences Corporation Company Profile 266
16.32 ev3 Inc. Company Profile 273
16.33 Kensey Nash Corporation Company Profile 279
16.34 Philips Healthcare Company Profile 281
16.35 Thoratec Corporation Company Profile 287
16.36 W. L. Gore & Associates, Inc. Company Profile 293
16.37 Welch Allyn Inc. Company Profile 295
17 Financial Deals Landscape 296
17.1 Merger 296
17.2 Acquisition 298
17.3 Venture Financing 307
17.4 Equity Offerings 332
17.5 Debt Offerings 337
17.6 Partnerships 345
17.7 Asset Transactions 356
18 Recent Developments 361
18.1 Strategy And Business Planning 361
18.2 Research And Development 373
18.3 Legal and Regulatory 375
18.4 Government and Public Interest 383
18.5 Product Approvals 391
19 Appendix 409
19.1 GlobalData Research Methodology 409
19.2 Coverage 410
19.3 Secondary Research 410
19.4 Primary Research 411
19.5 Models 411
19.6 Forecasts 411
19.7 Expert Panel Validation 412
19.8 Currency Conversion 413
19.9 Contact Us 414
19.10 Disclaimer 414

1.1 List of Tables
Table 1: US Healthcare Expenditure, 2000-2007 38
Table 2: US Healthcare Expenditure by Age (per person), 2000-2003 39
Table 3: US Healthcare Expenditure by Sex (per person), 2000-2003 39
Table 4: US Healthcare Expenditure by Race (per person), 2000-2003 39
Table 5: US Personal Healthcare Expenditure by Type, 2000-2004 40
Table 6: US Personal Healthcare Expenditure by Source, 2000-2004 41
Table 7: Total Number of Doctors in the US, 2003-2010 44
Table 8: Number of Doctors by Specialty in the US, 2003-2010 45
Table 9: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 46
Table 10: Doctors by Region (Number per 10,000 Civilian Population), 2002-2004 (Cont.) 47
Table 11: Total Hospitals in the US, 2000-2004 48
Table 12: Community Hospitals by Number of Beds in the US, 2000-2004 48
Table 13: Number of Hospital Beds in the US, 2000-2004 48
Table 14: Number of Hospital Beds by Range in the US, 2000-2004 49
Table 15: US Healthcare Trade Statistics, 2001-2006 50
Table 16: Medical Equipment Registration Fee in US, 2007 57
Table 17: Medical Device Approval Time in US, 2004 57
Table 18: Cardiovascular Devices, US, Overall Revenue ($ mn), Historic, 2000-2008 63
Table 19: Cardiovascular Devices, US, Overall Revenue ($ mn), Forecast, 2008-2015 65
Table 20: Cardiovascular Devices, US, Category Volume (Units), Historic, 2000-2008 66
Table 21: Cardiovascular Devices, US, Category Volume (Units), Forecast, 2008-2015 67
Table 22: Cardiovascular Devices, US, Cross-Category Analysis, 2000-2015 68
Table 23: Cardiovascular Devices, US, Company Share by Revenue ($ mn), 2007-2008 69
Table 24: Cardiac Rhythm Management, US, Revenue ($ mn) by Segment, Historic, 2000-2008 71
Table 25: Cardiac Rhythm Management, US, Revenue ($ mn) by Segment, Forecast, 2008-2015 72
Table 26: Cardiac Resynchronization Therapy, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 73
Table 27: Cardiac Resynchronization Therapy, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 74
Table 28: Implantable Cardioverter Defibrillator, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 75
Table 29: Implantable Cardioverter Defibrillator, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 76
Table 30: Pacemaker, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 77
Table 31: Pacemaker, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 78
Table 32: Cardiac Rhythm Management, US, Volume (Units) by Sub-Segment, Historic, 2000-2008 79
Table 33: Cardiac Rhythm Management, US, Volume (Units) by Sub-Segment, Forecast, 2008-2015 80
Table 34: Cardiac Rhythm Management, US, Average Price ($), Historic, 2000-2008 81
Table 35: Cardiac Rhythm Management, US, Average Price ($), Forecast, 2008-2015 81
Table 36: Cardiac Rhythm Management, US, Portfolio Analysis, 2000-2015 82
Table 37: Cardiac Rhythm Management, US, Distribution Share by Revenue ($mn), 2007-2008 84
Table 38: Cardiac Rhythm Management, US, Company Share by Revenue ($ mn), 2007-2008 85
Table 39: Cardiovascular Monitoring and Diagnostic Devices, US, Revenue ($ mn) by Segment, Historic, 2000-2008 88
Table 40: Cardiovascular Monitoring and Diagnostic Devices, US, Revenue ($ mn) by Segment, Forecast, 2008-2015 89
Table 41: Cardiovascular Monitoring and Diagnostic Devices, US, Volume (Units) by Segment, Historic, 2000-2008 90
Table 42: Cardiovascular Monitoring and Diagnostic Devices, US, Volume (Units) by Segment, Forecast, 2008-2015 91
Table 43: Cardiovascular Monitoring and Diagnostic Devices, US, Average Price ($), Historic, 2000-2008 92
Table 44: Cardiovascular Monitoring and Diagnostic Devices, US, Average Price ($), Forecast, 2008-2015 92
Table 45: Cardiovascular Monitoring and Diagnostic Devices, US, Cross Segment Analysis, 2000-2015 93
Table 46: Cardiovascular Monitoring and Diagnostic Devices, US, Distribution Share by Revenue ($mn), 2007-2008 94
Table 47: Cardiovascular Monitoring and Diagnostic Devices, US, Company Share by Revenue ($ mn), 2007-2008 95
Table 48: Cardiovascular Prosthetic Devices, US, Revenue ($ mn) by Segment, Historic, 2000-2008 97
Table 49: Cardiovascular Prosthetic Devices, US, Revenue ($ mn) by Segment, Forecast, 2008-2015 99
Table 50: Cardiac Assist Devices, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 101
Table 51: Cardiac Assist Devices, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 102
Table 52: Prosthetic Heart Valve, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 104
Table 53: Prosthetic Heart Valve, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 105
Table 54: Cardiovascular Prosthetic Devices, US, Overall Volume (Units), Historic, 2000-2008 106
Table 55: Cardiovascular Prosthetic Devices, US, Overall Volume (Units), Historic, 2008-2015 107
Table 56: Cardiovascular Prosthetic Devices, US, Average Price ($), Historic, 2000-2008 108
Table 57: Cardiovascular Prosthetic Devices, US, Average Price ($), Forecast, 2008-2015 108
Table 58: Cardiovascular Prosthetic Devices, US, Portfolio Analysis, 2000-2015 109
able 59: Cardiovascular Prosthetic Devices, US, Distribution Share by Revenue ($mn), 2007-2008 111
Table 60: Cardiovascular Prosthetic Devices, US, Company Share by Revenue ($ mn), 2007-2008 112
Table 61: Cardiovascular Surgery, US, Revenue ($ mn) by Segment, Historic, 2000-2008 114
Table 62: Cardiovascular Surgery, US, Revenue ($ mn) by Segment, Forecast, 2008-2015 116
Table 63: Cardiovascular Surgery, US, Overall Volume (Units), Historic, 2000-2008 117
Table 64: Cardiovascular Surgery, US, Overall Volume (Units), Forecast, 2008-2015 118
Table 65: Cardiovascular Surgery, US, Average Price ($), Historic, 2000-2008 119
Table 66: Cardiovascular Surgery, US, Average Price ($), Forecast, 2008-2015 119
Table 67: Cardiovascular Surgery, US, Portfolio Analysis, 2000-2015 120
Table 68: Cardiovascular Surgery, US, Distribution Share by Revenue ($mn), 2007-2008 122
Table 69: Cardiovascular Surgery, US, Company Share by Revenue ($ mn), 2007-2008 123
Table 70: Electrophysiology, US, Revenue ($ mn) by Segment, Historic, 2000-2008 125
Table 71: Electrophysiology, US, Revenue ($ mn) by Segment, Forecast, 2008-2015 126
Table 72: Electrophysiology, US, Volume (Units) by Segment, Historic, 2000-2008 127
Table 73: Electrophysiology, US, Volume (Units) by Segment, Forecast, 2008-2015 127
Table 74: Electrophysiology, US, Average Price ($), Historic, 2000-2008 128
Table 75: Electrophysiology, US, Average Price ($), Forecast, 2008-2015 128
Table 76: Electrophysiology, US, Portfolio Analysis, 2000-2015 129
Table 77: Cardiovascular Surgery, US, Distribution Share by Revenue ($mn), 2007-2008 131
Table 78: Electrophysiology, US, Company Share by Revenue ($ mn), 2007-2008 132
Table 79: Interventional Cardiology, US, Revenue ($ mn) by Segment, Historic, 2000-2008 135
Table 80: Interventional Cardiology, US, Revenue ($ mn) by Segment, Forecast, 2008-2015 137
Table 81: Cardiac Catheter, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 138
Table 82: Cardiac Catheter, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 139
Table 83: Coronary Stent, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 140
Table 84: Coronary Stent, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 142
Table 85: PTCA Balloon, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 143
Table 86: PTCA Balloon, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 144
Table 87: Interventional Cardiology, US, Overall Volume (Units), Historic, 2000-2008 145
Table 88: Interventional Cardiology, US, Overall Volume (Units), Forecast, 2008-2015 146
Table 89: Interventional Cardiology, US, Average Price ($), Historic, 2000-2008 147
Table 90: Interventional Cardiology, US, Average Price ($), Forecast, 2008-2015 148
Table 91: Interventional Cardiology, US, Portfolio Analysis, 2000-2015 149
Table 92: Interventional Cardiology, US, Distribution Share by Revenue ($mn), 2007-2008 151
Table 93: Interventional Cardiology, US, Company Share by Revenue ($ mn), 2007-2008 152
Table 94: Peripheral Vascular Devices, US, Revenue ($ mn) by Segment, Historic, 2000-2008 155
Table 95: Peripheral Vascular Devices, US, Revenue ($ mn) by Segment, Forecast, 2008-2015 156
Table 96: Peripheral Vascular Devices, US, Volume (Units) by Segment, Historic, 2000-2008 159
Table 97: Peripheral Vascular Devices, US, Volume (Units) by Segment, Forecast, 2008-2015 160
Table 98: Peripheral Vascular Devices, US, Average Price ($), Historic, 2000-2008 162
Table 99: Peripheral Vascular Devices, US, Average Price ($), Forecast, 2008-2015 162
Table 100: Peripheral Vascular Devices, US, Portfolio Analysis, 2000-2015 163
Table 101: Peripheral Vascular Devices, US, Distribution Share by Revenue ($mn), 2007-2008 165
Table 102: Peripheral Vascular Devices, US, Company Share by Revenue ($ mn), 2007-2008 166
Table 103: Boston Scientific Corporation Pipeline Products by Equipment Type 172
Table 104: Boston Scientific Corporation Pipeline Products By Development Stage 173
Table 105: Boston Scientific Corporation Pipeline Products By Therapy Area 174
Table 106: Boston Scientific Corporation Pipeline Products By Clinical Trials 175
Table 107: Boston Scientific Corporation Pipeline Products By News Summaries 176
Table 108: Medtronic, Inc. Pipeline Products by Equipment Type 181
Table 109: Medtronic, Inc. Pipeline Products By Development Stage 183
Table 110: Medtronic, Inc. Pipeline Products By Therapy Area 185
Table 111: Medtronic, Inc. Pipeline Products By Clinical Trials 187
Table 112: Medtronic, Inc. Pipeline Products By News Summaries 188
Table 113: Cordis Corporation Pipeline Products by Equipment Type 189
Table 114: Cordis Corporation Pipeline Products By Development Stage 190
Table 115: Cordis Corporation Pipeline Products By Therapy Area 190
Table 116: Cordis Corporation Pipeline Products By Clinical Trials 191
Table 117: Cordis Corporation Pipeline Products By News Summaries 191
Table 118: St. Jude Medical Inc. Pipeline Products by Equipment Type 196
Table 119: St. Jude Medical Inc. Pipeline Products By Development Stage 196
Table 120: St. Jude Medical Inc. Pipeline Products By Therapy Area 197
Table 121: St. Jude Medical Inc. Pipeline Products By Clinical Trials 197
Table 122: St. Jude Medical Inc. Pipeline Products By News Summaries 198
Table 123: Abbott Laboratories Pipeline Products by Equipment Type 202
Table 124: Abbott Laboratories Pipeline Products By Development Stage 203
Table 125: Abbott Laboratories Pipeline Products By Therapy Area 203
Table 126: Abbott Laboratories Pipeline Products By Clinical Trials 203
Table 127: Abbott Laboratories Pipeline Products By News Summaries 203
Table 128: Terumo Corporation Pipeline Products by Equipment Type 206
Table 129: Terumo Corporation Pipeline Products By Development Stage 206
Table 130: Terumo Corporation Pipeline Products By Therapy Area 207
Table 131: Terumo Corporation Pipeline Products By Clinical Trials 208
Table 132: Terumo Corporation Pipeline Products By News Summaries 208
Table 133: Abbott Vascular Pipeline Products by Equipment Type 209
Table 134: Abbott Vascular Pipeline Products By Development Stage 210
Table 135: Abbott Vascular Pipeline Products By Therapy Area 210
Table 136: Abbott Vascular Pipeline Products By Clinical Trials 211
Table 137: Abbott Vascular Pipeline Products By News Summaries 212
Table 138: ABIOMED, Inc. Pipeline Products by Equipment Type 216
Table 139: ABIOMED, Inc. Pipeline Products By Development Stage 217
Table 140: ABIOMED, Inc. Pipeline Products By Therapy Area 217
Table 141: ABIOMED, Inc. Pipeline Products By Clinical Trials 217
Table 142: ABIOMED, Inc. Pipeline Products By News Summaries 217
Table 143: AGA Medical Corporation Pipeline Products by Equipment Type 218
Table 144: AGA Medical Corporation Pipeline Products By Development Stage 218
Table 145: AGA Medical Corporation Pipeline Products By Therapy Area 219
Table 146: AGA Medical Corporation Pipeline Products By Clinical Trials 219
Table 147: AGA Medical Corporation Pipeline Products By News Summaries 219
Table 148: Angel Medical Systems, Inc. Pipeline Products by Equipment Type 220
Table 149: Angel Medical Systems, Inc. Pipeline Products by Development Stage 220
Table 150: Angel Medical Systems, Inc. Pipeline Products By Therapy Area 220
Table 151: Angel Medical Systems, Inc. Pipeline Products By Clinical Trials 220
Table 152: Angel Medical Systems, Inc. Pipeline Products By News Summaries 220
Table 153: Arrow International, Inc. Pipeline Products by Equipment Type 224
Table 154: Arrow International, Inc. Pipeline Products By Development Stage 224
Table 155: Arrow International, Inc. Pipeline Products By Therapy Area 224
Table 156: Arrow International, Inc. Pipeline Products By Clinical Trials 225
Table 157: Ash Access Technology, Inc. Pipeline Products by Equipment Type 226
Table 158: Ash Access Technology, Inc. Pipeline Products By Development Stage 226
Table 159: Ash Access Technology, Inc. Pipeline Products By Therapy Area 226
Table 160: AtriCure, Inc. Pipeline Products by Equipment Type 227
Table 161: AtriCure, Inc. Pipeline Products By Development Stage 227
Table 162: AtriCure, Inc. Pipeline Products By Therapy Area 228
Table 163: AtriCure, Inc. Pipeline Products By Clinical Trials 228
Table 164: AtriCure, Inc. Pipeline Products By News Summaries 228
Table 165: Atritech, Inc. Pipeline Products by Equipment Type 229
Table 166: Atritech, Inc. Pipeline Products by Development Stage 229
Table 167: Atritech, Inc. Pipeline Products By Therapy Area 230
Table 168: Atritech, Inc. Pipeline Products By Clinical Trials 230
Table 169: Atritech, Inc. Pipeline Products By News Summaries 230
Table 170: Atrium Medical Corporation Pipeline Products by Equipment Type 231
Table 171: Atrium Medical Corporation Pipeline Products By Development Stage 231
Table 172: Atrium Medical Corporation Pipeline Products By Therapy Area 232
Table 173: Atrium Medical Corporation Pipeline Products By Clinical Trials 232
Table 174: ATS Medical, Inc. Pipeline Products by Equipment Type 233
Table 175: ATS Medical, Inc. Pipeline Products By Development Stage 233
Table 176: ATS Medical, Inc. Pipeline Products By Therapy Area 234
Table 177: ATS Medical, Inc. Pipeline Products By Clinical Trials 234
Table 178: ATS Medical, Inc. Pipeline Products By News Summaries 234
Table 179: BioCardia, Inc. Pipeline Products by Equipment Type 235
Table 180: BioCardia, Inc. Pipeline Products by Development Stage 235
Table 181: BioCardia, Inc. Pipeline Products By Therapy Area 235
Table 182: BioCardia, Inc. Pipeline Products By Clinical Trials 235
Table 183: Bioheart, Inc. Pipeline Products by Equipment Type 236
Table 184: Bioheart, Inc. Pipeline Products By Development Stage 236
Table 185: Bioheart, Inc. Pipeline Products By Therapy Area 237
Table 186: Bioheart, Inc. Pipeline Products By Clinical Trials 237
Table 187: Bioheart, Inc. Pipeline Products By News Summaries 237
Table 188: Biosite Incorporated Pipeline Products by Equipment Type 241
Table 189: Biosite Incorporated Pipeline Products By Development Stage 242
Table 190: Biosite Incorporated Pipeline Products By Therapy Area 242
Table 191: Biosite Incorporated Pipeline Products By Clinical Trials 242
Table 192: Biosite Incorporated Pipeline Products By News Summaries 243
Table 193: BIOTRONIK GmbH & Co. KG Pipeline Products by Equipment Type 244
Table 194: BIOTRONIK GmbH & Co. KG Pipeline Products By Development Stage 244
Table 195: BIOTRONIK GmbH & Co. KG Pipeline Products By Therapy Area 245
Table 196: BIOTRONIK GmbH & Co. KG Pipeline Products By Clinical Trials 245
Table 197: BIOTRONIK GmbH & Co. KG Pipeline Products By News Summary 245
Table 198: Bolton Medical, Inc. Pipeline Products by Equipment Type 246
Table 199: Bolton Medical, Inc. Pipeline Products by Development Stage 246
Table 200: Bolton Medical, Inc. Pipeline Products By Therapy Area 246
Table 201: Bolton Medical, Inc. Pipeline Products By Clinical Trials 246
Table 202: Bolton Medical, Inc. Pipeline Products By News Summaries 246
Table 203: C.R. Bard, Inc. Pipeline Products by Equipment Type 250
Table 204: C.R. Bard, Inc. Pipeline Products By Development Stage 251
Table 205: C.R. Bard, Inc. Pipeline Products By Therapy Area 251
Table 206: C.R. Bard, Inc. Pipeline Products By Clinical Trials 252
Table 207: C.R. Bard, Inc. Pipeline Products By News Summaries 252
Table 208: Cardiac Dimensions, Inc. Pipeline Products by Equipment Type 253
Table 209: Cardiac Dimensions, Inc. Pipeline Products by Development Stage 253
Table 210: Cardiac Dimensions, Inc. Pipeline Products By Therapy Area 253
Table 211: Cardiac Dimensions, Inc. Pipeline Products By Clinical Trials 254
Table 212: Cardiac Dimensions, Inc. Pipeline Products By News Summaries 254
Table 213: Cardima, Inc. Pipeline Products by Equipment Type 259
Table 214: Cardima, Inc. Pipeline Products By Development Stage 259
Table 215: Cardima, Inc. Pipeline Products By Therapy Area 259
Table 216: Cardima, Inc. Pipeline Products By Clinical Trials 260
Table 217: Cardima, Inc. Pipeline Products By News Summaries 260
Table 218: Cardiovascular Systems, Inc. Pipeline Products by Equipment Type 261
Table 219: Cardiovascular Systems, Inc. Pipeline Products by Development Stage 261
Table 220: Cardiovascular Systems, Inc. Pipeline Products By Therapy Area 261
Table 221: Cardiovascular Systems, Inc. Pipeline Products By News Summaries 261
Table 222: Cook Medical Pipeline Products by Equipment Type 266
Table 223: Cook Medical Pipeline Products By Development Stage 266
Table 224: Cook Medical Pipeline Products By Therapy Area 267
Table 225: Cook Medical Pipeline Products By Clinical Trials 267
Table 226: Cook Medical Pipeline Products By News Summaries 268
Table 227: Datascope Corporation Pipeline Products by Equipment Type 273
Table 228: Datascope Corporation Pipeline Products by Development Stage 273
Table 229: Datascope Corporation Pipeline Products By Therapy Area 273
Table 230: Datascope Corporation Pipeline Products By News Summaries 273
Table 231: Edwards Lifesciences Corporation Pipeline Products by Equipment Type 278
Table 232: Edwards Lifesciences Corporation Pipeline Products By Development Stage 278
Table 233: Edwards Lifesciences Corporation Pipeline Products By Therapy Area 279
Table 234: Edwards Lifesciences Corporation Pipeline Products By Clinical Trials 279
Table 235: Edwards Lifesciences Corporation Pipeline Products By News Summaries 280
Table 236: ev3 Inc. Pipeline Products by Equipment Type 284
Table 237: ev3 Inc. Pipeline Products By Development Stage 285
Table 238: ev3 Inc. Pipeline Products By Therapy Area 285
Table 239: ev3 Inc. Pipeline Products By Clinical Trials 286
Table 240: ev3 Inc. Pipeline Products By News Summaries 286
Table 241: Kensey Nash Corporation Pipeline Products by Equipment Type 287
Table 242: Kensey Nash Corporation Pipeline Products By Development Stage 287
Table 243: Kensey Nash Corporation Pipeline Products By Therapy Area 288
Table 244: Kensey Nash Corporation Pipeline Products By Clinical Trials 288
Table 245: Kensey Nash Corporation Pipeline Products By News Summaries 288
Table 246: Philips Healthcare Pipeline Products by Equipment Type 293
Table 247: Philips Healthcare Pipeline Products By Development Stage 293
Table 248: Philips Healthcare Pipeline Products By Therapy Area 294
Table 249: Philips Healthcare Pipeline Products By Clinical Trials 294
Table 250: Philips Healthcare Pipeline Products By News Summaries 294

1.2 List of Figures
Figure 1: US, Healthcare Expenditure by Source, 2007 38
Figure 2: US, Healthcare Infrastructure, Top Level View, 2007 43
Figure 3: Healthcare Expenses Segmentation by End User 44
Figure 4: Medical Equipment Approval Process in the US, 2007 52
Figure 5: PMA Approval Process in the US, 2007 54
Figure 6: The 510(k) Approval Process for Medical Devices in the US, 2007 55
Figure 7: Reimbursement Structure in the US, 2007 60
Figure 8: Distribution Structure of Medical Equipment in the US, 2006 61
Figure 9: Cardiovascular Devices, US, Overall Revenue ($ mn), Historic, 2000-2008 62
Figure 10: Cardiovascular Devices, US, Overall Revenue ($ mn), Forecast, 2008-2015 64
Figure 11: Cardiovascular Devices, US, Cross-Category Analysis, 2000-2015 68
Figure 12: Cardiovascular Devices, US, Company Share (%), 2008 69
Figure 13: Cardiac Rhythm Management, US, Revenue ($ mn) by Segment, Historic, 2000-2008 70
Figure 14: Cardiac Rhythm Management, US, Revenue ($ mn) by Segment, Forecast, 2008-2015 72
Figure 15: Cardiac Resynchronization Therapy, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 73
Figure 16: Cardiac Resynchronization Therapy, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 74
Figure 17: Implantable Cardioverter Defibrillator, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 75
Figure 18: Implantable Cardioverter Defibrillator, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 76
Figure 19: Pacemaker, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 77
Figure 20: Pacemaker, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 78
Figure 21: Cardiac Rhythm Management, US, Cross Segment Analysis, 2000-2015 82
Figure 22: Cardiac Rhythm Management, US, Company Share (%), 2008 85
Figure 23: Cardiovascular Monitoring and Diagnostic Devices, US, Revenue ($ mn) by Segment, Historic, 2000-2008 87
Figure 24: Cardiovascular Monitoring and Diagnostic Devices, US, Revenue ($ mn) by Segment, Forecast, 2008-2015 89
Figure 25: Cardiovascular Monitoring and Diagnostic Devices, US, Volume (Units) by Segment, Historic, 2000-2008 90
Figure 26: Cardiovascular Monitoring and Diagnostic Devices, US, Volume (Units) by Segment, Forecast, 2008-2015 91
Figure 27: Cardiovascular Monitoring and Diagnostic Devices, US, Cross Segment Analysis, 2000-2015 93
Figure 28: Cardiovascular Monitoring and Diagnostic Devices, US, Company Share (%), 2008 95
Figure 29: Cardiovascular Prosthetic Devices, US, Revenue ($ mn) by Segment, Historic, 2000-2008 97
Figure 30: Cardiovascular Prosthetic Devices, US, Revenue ($ mn) by Segment, Forecast, 2008-2015 99
Figure 31: Cardiac Assist Devices, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 101
Figure 32: Cardiac Assist Devices, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 102
Figure 33: Prosthetic Heart Valve, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 104
Figure 34: Prosthetic Heart Valve, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 105
Figure 35: Cardiovascular Prosthetic Devices, US, Cross Segment Analysis, 2000-2015 109
Figure 36: Cardiovascular Prosthetic Devices, US, Company Share (%), 2008 112
Figure 37: Cardiovascular Surgery, US, Revenue ($ mn) by Segment, Historic, 2000-2008 114
Figure 38: Cardiovascular Surgery, US, Revenue ($ mn) by Segment, Forecast, 2008-2015 116
Figure 39: Cardiovascular Surgery, US, Cross Segment Analysis, 2000-2015 120
Figure 40: Cardiovascular Surgery, US, Company Share (%), 2008 123
Figure 41: Electrophysiology, US, Revenue ($ mn) by Segment, Historic, 2000-2008 125
Figure 42: Electrophysiology, US, Revenue ($ mn) by Segment, Forecast, 2008-2015 126
Figure 43: Electrophysiology, US, Cross Segment Analysis, 2000-2015 129
Figure 44: Electrophysiology, US, Company Share (%), 2008 132
Figure 45: Interventional Cardiology, US, Revenue ($ mn) by Segment, Historic, 2000-2008 134
Figure 46: Interventional Cardiology, US, Revenue ($ mn) by Segment, Forecast, 2008-2015 136
Figure 47: Cardiac Catheter, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 138
Figure 48: Cardiac Catheter, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 139
Figure 49: Coronary Stent, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 140
Figure 50: Coronary Stent, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 142
Figure 51: PTCA Balloon, US, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 143
Figure 52: PTCA Balloon, US, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 144
Figure 53: Interventional Cardiology, US, Cross Segment Analysis, 2000-2015 149
Figure 54: Interventional C

Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.